Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden.
Department of Paediatrics, Skåne University Hospital, Malmö, Sweden.
PLoS One. 2018 Sep 14;13(9):e0203692. doi: 10.1371/journal.pone.0203692. eCollection 2018.
Low-energy fractures are a growing health challenge as their incidence increases with advancing age. As cardiovascular instability may be associated with higher likelihood of traumatic falls, we aimed to investigate the associations between four cardiovascular biomarkers and the risk of low-energy fractures in a middle-aged population.
A total of 5291 individuals from the prospective Malmö Diet and Cancer (MDC) study (mean age, 57 years; 59% women) with data on baseline levels of four cardiovascular biomarkers: mid-regional-fragment of pro-adrenomedullin-peptide (MR-pro-ADM), mid-regional-fragment of pro-atrial-natriuretic-peptide (MR-proANP), N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and C-terminal-pro-arginine-vasopressin (CT-pro-AVP/Copeptin) were included. The associations between biomarker levels and first incident low-energy fracture were tested in Cox proportional-hazard models, taking potential interactions and traditional risk factors into account.
Participants were followed for a median time of 21.0 years, during which 1002 subjects (19%) experienced at least one low-energy fracture. Subjects with incident fracture were older, more likely to be women, had lower BMI and higher prevalence of previous fractures. Among biomarkers, there was a significant interaction between gender and MR-pro-ADM on the risk of fracture (p = 0.002). MR-pro-ADM predicted fractures in men only (hazard ratio, 1.23; 95% CI 1.09-1.40; p = 0.001), whereas there was no association among women. Levels of MR-pro-ANP, NT-pro-BNP and CT-pro-AVP did not predict fractures.
Higher circulating levels of MR-pro-ADM predict low-energy fractures among middle-aged-men, whereas levels of MR-pro-ANP, NT-pro-BNP and CT-pro-AVP are not associated with increased fracture risk. Further controlled studies should test the hypothesis whether MR-pro-ADM may improve prediction of bone fractures.
随着年龄的增长,低能量骨折的发病率不断增加,成为一个日益严重的健康挑战。由于心血管不稳定可能与更高的创伤性跌倒风险相关,我们旨在研究中年人群中四种心血管生物标志物与低能量骨折风险之间的关系。
共纳入来自前瞻性马尔默饮食与癌症研究(MDC)的 5291 名个体(平均年龄 57 岁,59%为女性),他们的数据包括四种心血管生物标志物的基线水平:中区域片段促肾上腺髓质肽(MR-pro-ADM)、中区域片段心钠肽前体(MR-proANP)、N 末端脑利钠肽前体(NT-pro-BNP)和 C 末端脯氨酸血管加压素(CT-pro-AVP/Copeptin)。在考虑潜在的相互作用和传统危险因素的情况下,使用 Cox 比例风险模型检验了生物标志物水平与首次低能量骨折事件之间的关系。
参与者的中位随访时间为 21.0 年,在此期间,1002 名受试者(19%)经历了至少一次低能量骨折。发生骨折的受试者年龄较大,更可能为女性,体重指数较低,既往骨折发生率较高。在生物标志物中,性别和 MR-pro-ADM 之间存在骨折风险的显著交互作用(p = 0.002)。MR-pro-ADM 仅预测男性骨折(风险比,1.23;95%CI 1.09-1.40;p = 0.001),而女性则没有相关性。MR-pro-ANP、NT-pro-BNP 和 CT-pro-AVP 的水平与骨折无关。
循环中较高水平的 MR-pro-ADM 预测中年男性的低能量骨折,而 MR-pro-ANP、NT-pro-BNP 和 CT-pro-AVP 的水平与骨折风险增加无关。进一步的对照研究应检验假设,即 MR-pro-ADM 是否可以改善骨折风险的预测。